# A novel intravascular navigational ultrasound system for transjugular intrahepatic portosystemic shunt procedures

**Authors:** Lei Xiao, Guanqiang Li, Bo Hu, Ming Chen, Yuan Sun, Xicheng Zhang, Xiaohua Jian, Xianchen Huang

PMC · DOI: 10.1186/s42155-025-00642-y · CVIR Endovascular · 2025-12-31

## TL;DR

A new ultrasound system improves accuracy and safety during a complex liver procedure, reducing complications and radiation exposure.

## Contribution

A novel intravascular navigational ultrasound system is introduced for safer and more efficient TIPS procedures.

## Key findings

- The IVNU system successfully punctured each lobe in in vitro experiments.
- In vivo studies showed IVNU reduced punctures, procedure time, fluoroscopy time, and radiation dose.
- Puncture-related complications were significantly lower with IVNU compared to conventional methods.

## Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) is an effective method for reducing portal hypertension in patients with decompensated cirrhosis. However, portal vein puncture is associated with a steep learning curve. Conventional “blind” puncture methods are often imprecise, carry a high risk of complications, and require significant radiation exposure. To increase puncture accuracy, we developed an intravascular navigational ultrasound (IVNU) system. This study aimed to evaluate the feasibility, efficacy, and safety of IVNU for portal vein puncture during TIPS procedures.

In the in vitro experiment, we performed punctures using IVNU in four isolated porcine livers. Subsequently, in the in vivo animal study, eight Bama swine (Sus scrofa) were randomly assigned to undergo TIPS using either IVNU (experimental group) or conventional “blind” puncture with the RUPS100 COOK kit (control group).

In our in vitro experiment, the IVNU system successfully punctured each lobe. In our in vivo study, all the procedures successfully established portosystemic shunts. The IVNU group exhibited significantly fewer punctures (1.8 ± 0.4 vs. 4.2 ± 1.1), shorter procedure times (32.5 ± 4.2 min vs. 58.7 ± 6.5 min), shorter fluoroscopy times (8.1 ± 1.3 min vs. 20.4 ± 2.1 min), and lower radiation doses (579.5 ± 45.9 mGy vs. 1305.7 ± 50.4 mGy) than the control group (all P < 0.01). Puncture-related complications were also significantly reduced in the IVNU group.

These findings indicate that IVNU significantly improves portal vein targeting success, reduces the risk of puncture-related complications and radiation exposure, and decreases procedure time, offering clinicians an optimized solution for TIPS creation.

## Linked entities

- **Diseases:** portal hypertension (MONDO:0005080)
- **Species:** Sus scrofa (taxon 9823)

## Full-text entities

- **Diseases:** portal hypertension (MESH:D006975), cirrhosis (MESH:D005355)
- **Species:** Homo sapiens (human, species) [taxon 9606], Sus scrofa (pig, species) [taxon 9823]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12756212/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12756212/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12756212/full.md

---
Source: https://tomesphere.com/paper/PMC12756212